1.
Pediatr Blood Cancer
; 69(5): e29530, 2022 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34913591
2.
J Pediatr Hematol Oncol
; 37(6): e399-401, 2015 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26056788
RESUMO
There are no approved medical therapies for the treatment of pediatric central giant cell granuloma (CGCG), a benign but potentially aggressive tumor of the jaw. Zoledronic acid (ZA), a third-generation bisphosphonate, has been used in CGCG occurring in adults. We describe 4 patients with CGCG treated with ZA, 3 of whom achieved resolution of disease up to 4 years of follow-up. Our experience suggests that ZA may be considered as treatment for pediatric CGCG.